These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 20535647)

  • 1. Plasma kallikrein and diabetic macular edema.
    Feener EP
    Curr Diab Rep; 2010 Aug; 10(4):270-5. PubMed ID: 20535647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Plasma Kallikrein-Kinin Pathway in the Development of Diabetic Retinopathy: Pathophysiology and Therapeutic Approaches.
    Abdulaal M; Haddad NM; Sun JK; Silva PS
    Semin Ophthalmol; 2016; 31(1-2):19-24. PubMed ID: 26959125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma kallikrein-kinin system and diabetic retinopathy.
    Liu J; Feener EP
    Biol Chem; 2013 Mar; 394(3):319-28. PubMed ID: 23362193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Kallikrein-kinin system as a target for diabetic retinopathy treatment].
    Iarovaia GA; Neshkova EA; Blokhina TB; Kochergin SA; Vorob'eva IV; Gigineishvili DN
    Vestn Oftalmol; 2012; 128(4):78-81. PubMed ID: 22994115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stable and Long-Lasting, Novel Bicyclic Peptide Plasma Kallikrein Inhibitors for the Treatment of Diabetic Macular Edema.
    Teufel DP; Bennett G; Harrison H; van Rietschoten K; Pavan S; Stace C; Le Floch F; Van Bergen T; Vermassen E; Barbeaux P; Hu TT; Feyen JHM; Vanhove M
    J Med Chem; 2018 Apr; 61(7):2823-2836. PubMed ID: 29517911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma Kallikrein Mediates Vascular Endothelial Growth Factor-Induced Retinal Dysfunction and Thickening.
    Clermont A; Murugesan N; Zhou Q; Kita T; Robson PA; Rushbrooke LJ; Evans DM; Aiello LP; Feener EP
    Invest Ophthalmol Vis Sci; 2016 May; 57(6):2390-9. PubMed ID: 27138737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the kallikrein-kinin system as a new therapeutic approach to diabetic retinopathy.
    Pruneau D; Bélichard P; Sahel JA; Combal JP
    Curr Opin Investig Drugs; 2010 May; 11(5):507-14. PubMed ID: 20419596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The kallikrein-kinin system in diabetic retinopathy: lessons for the kidney.
    Phipps JA; Feener EP
    Kidney Int; 2008 May; 73(10):1114-9. PubMed ID: 18272958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigational plasma kallikrein inhibitors for the treatment of diabetic macular edema: an expert assessment.
    Bhatwadekar AD; Kansara VS; Ciulla TA
    Expert Opin Investig Drugs; 2020 Mar; 29(3):237-244. PubMed ID: 31985300
    [No Abstract]   [Full Text] [Related]  

  • 10. Kallikrein-kinin activation by altered vitreous pH: New perspectives for treatment and pathogenesis of diabetic macular edema? : Comment on: Gao BB et al. Extracellular carbonic anhydrase mediates hemorrhagic retinal and cerebral vascular permeability through prekallikrein activation. Nat Med. 2007 Feb;13(2):181-8.
    Zeitz O; Keserü M
    Graefes Arch Clin Exp Ophthalmol; 2007 Dec; 245(12):1745-7. PubMed ID: 17823811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The plasma and tissue kininogen-kallikrein-kinin system: role in the cardiovascular system.
    Marcondes S; Antunes E
    Curr Med Chem Cardiovasc Hematol Agents; 2005 Jan; 3(1):33-44. PubMed ID: 15638742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma Kallikrein-Kinin System as a VEGF-Independent Mediator of Diabetic Macular Edema.
    Kita T; Clermont AC; Murugesan N; Zhou Q; Fujisawa K; Ishibashi T; Aiello LP; Feener EP
    Diabetes; 2015 Oct; 64(10):3588-99. PubMed ID: 25979073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma kallikrein: the bradykinin-producing enzyme.
    Björkqvist J; Jämsä A; Renné T
    Thromb Haemost; 2013 Sep; 110(3):399-407. PubMed ID: 23846131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinal proteome associated with bradykinin-induced edema.
    Murugesan N; Fickweiler W; Clermont AC; Zhou Q; Feener EP
    Exp Eye Res; 2019 Sep; 186():107744. PubMed ID: 31351056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophils engage the kallikrein-kinin system to open up the endothelial barrier in acute inflammation.
    Kenne E; Rasmuson J; Renné T; Vieira ML; Müller-Esterl W; Herwald H; Lindbom L
    FASEB J; 2019 Feb; 33(2):2599-2609. PubMed ID: 30281335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular carbonic anhydrase mediates hemorrhagic retinal and cerebral vascular permeability through prekallikrein activation.
    Gao BB; Clermont A; Rook S; Fonda SJ; Srinivasan VJ; Wojtkowski M; Fujimoto JG; Avery RL; Arrigg PG; Bursell SE; Aiello LP; Feener EP
    Nat Med; 2007 Feb; 13(2):181-8. PubMed ID: 17259996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the plasma kallikrein/kinin system on endothelial cell membranes.
    Røjkjaer R; Schmaier AH
    Immunopharmacology; 1999 Sep; 43(2-3):109-14. PubMed ID: 10596841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The kallikrein-kinin system in diabetic retinopathy.
    Bhat M; Pouliot M; Couture R; Vaucher E
    Prog Drug Res; 2014; 69():111-43. PubMed ID: 25130041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of Factor XII and Kallikrein-Kinin System Combined with Neutrophil Extracellular Trap Formation in Diabetic Retinopathy.
    Song DY; Gu JY; Yoo HJ; Kim YI; Nam-Goong IS; Kim ES; Kim HK
    Exp Clin Endocrinol Diabetes; 2021 Aug; 129(8):560-565. PubMed ID: 31426112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and cellular localization of the kallikrein-kinin system in human ocular tissues.
    Ma JX; Song Q; Hatcher HC; Crouch RK; Chao L; Chao J
    Exp Eye Res; 1996 Jul; 63(1):19-26. PubMed ID: 8983960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.